Non-pharmacological randomized intervention trial for the management of neuropsychological symptoms in outpatients with progressive multiple sclerosis.

Multiple sclerosis neuropsychology non-pharmacological intervention progressive disease course rehabilitation

Journal

Applied neuropsychology. Adult
ISSN: 2327-9109
Titre abrégé: Appl Neuropsychol Adult
Pays: United States
ID NLM: 101584082

Informations de publication

Date de publication:
31 Aug 2023
Historique:
medline: 1 9 2023
pubmed: 1 9 2023
entrez: 31 8 2023
Statut: aheadofprint

Résumé

Despite typically more pronounced cognitive and mental health issues in progressive disease courses of multiple sclerosis (PMS), rehabilitation research in this subgroup is rare. The efficacy of two non-pharmacological interventions with positive results from prior investigations was therefore examined in PMS specifically. Persons with PMS (pwPMS) received either computerized cognitive training (BrainStim), standardized cognitive-behavioral group sessions (Metacognitive Training [MaTiMS]), or a combination of both in an ambulatory setting. Neuropsychological assessment was conducted before and after the four-week intervention. 37 participants (13 with primary/24 with secondary PMS, mean While objective cognitive performance improved when explicitly trained, psychoeducative sessions contributed to subjective mental health. The combination of both approaches is thus suggested, considering the specific needs of pwPMS treated in an ambulatory setting.

Identifiants

pubmed: 37652158
doi: 10.1080/23279095.2023.2233648
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-13

Auteurs

Alina Renner (A)

Cogito Center for Applied Neurocognition and Neuropsychological Research, Düsseldorf, Germany.

Sharon Jean Bätge (SJ)

Cogito Center for Applied Neurocognition and Neuropsychological Research, Düsseldorf, Germany.

Melanie Filser (M)

Cogito Center for Applied Neurocognition and Neuropsychological Research, Düsseldorf, Germany.

Stephanie Lau (S)

Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Jana Pöttgen (J)

Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Iris-Katharina Penner (IK)

Cogito Center for Applied Neurocognition and Neuropsychological Research, Düsseldorf, Germany.
Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Classifications MeSH